Supernatants from dengue virus type-2 infected macrophages induce permeability changes in endothelial cell monolayers

Journal of Medical Virology

Volumn 69, Issue 4, 2003, Pages 521-528

  Carr, Jillian M ^a   Hocking, Helen ^a   Bunting, Karen ^b   Wright, Peter J ^c   Davidson, Andrew ^c   Gamble, Jennifer ^a   Burrell, Christopher J ^a,b   Li, Peng ^a,b  

^a INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Capillary leakage; Dengue haemorrhagic fever; Flavivirus; Human umbilical vein endothelial cell

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL MEMBRANE PERMEABILITY; DENGUE; DENGUE VIRUS; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MACROPHAGE; MONOCYTE; MONOLAYER CULTURE; NONHUMAN; SHOCK; SUPERNATANT; VIRUS CELL INTERACTION; VIRUS VIRULENCE;

CELL MEMBRANE PERMEABILITY; CELLS, CULTURED; DENGUE VIRUS; ENDOTHELIUM, VASCULAR; HUMANS; MACROPHAGES; MONOCYTES; TUMOR NECROSIS FACTOR-ALPHA; UMBILICAL VEINS;

DENGUE VIRUS; DENGUE VIRUS TYPE 2; FLAVIVIRUS;

EID: 0037400099     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.10340     Document Type: Article

References (44)

1. Agarwal R, Chaturvedi UC, Misra A, Mukerjee R, Kapoor S, Nagar R, Tandon R, Mathur A. 1998. Production of cytotoxic factor by peripheral blood mononuclear cells (PBMC) in patients with dengue haemorrhagic fever. Clin Exp Immunol 112:477-481.
2. Anderson R, Wang S, Osiowy C, Issekutz AC. 1997. Activation of endothelial cells via antibody-enhanced dengue virus infection of peripheral blood monocytes. J Virol 71:4226-4232.
3. Andrews BS. 1978. Replication of dengue and Junin viruses in cultured rabbit and human endothelial cells. Infect Immun 20:776-781.
4. Avirutnan P, Malasit P, Seliger B, Bhakdi S, Husmann M. 1998. Dengue virus infection of human endothelial cells leads to chemokine production, complement activation and apoptosis. J Immunol 161:6338-6346.
5. Bonner SM, O'Sullivan MA. 1998. Endothelial cell monolayers as a model system to investigate dengue shock syndrome. J Virol Methods 71:159-167.
6. Bosch I, Xhaja K, Estevez L, Raines G, Melichar H, Warke RV, Fournier MV, Ennis FA, Rothman AL. 2002. Increased production of interleukin-8 in primary human monocytes and in human epithelial and endothelial cell lines after dengue virus challenge. J Virol 76:5588-5597.
7. Bunyaratvej A, Butthep P, Yoksan S, Bhamarapravati N. 1997. Dengue viruses induce cell proliferation and morphological changes of endothelial cells. Southeast Asian J Trop Med Pub Health 28: 32-37.
8. Chang DM, Shaio MF. 1994. Production of Interleukin-1(IL-1) and IL-1 inhibitor by human monocytes exposed to dengue virus. J Infect Dis 170:811-817.
9. Chaturvedi UC, Agarwal R, Elbishbishi EA, Mustafa AS. 2000. Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesis. FEMS Immunol Med Microbiol. 28:183-188.
10. Diamond MS, Edgil D, Roberts TG, Lu B, Harris E. 2000. Infection of human cells by dengue virus is modulated by different cell types and viral strains. J Virol 74:7814-7823.
11. Feldman H, Bugany H, Mahner F, Klenk H-D, Drenckhan D, Schnittler H-J. 1996. Filovirus-induced endothelial leakage triggered by infected monocytes/macrophages. J Virol 70:2208-2214.
12. Gamble JR, Harla JM, Klebanoff SJ, Vadas MA. 1985. Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor. Proc Natl Acad Sci USA 82:8667-8671.
13. Gibbs LS, Lai L, Malik AB. 1990. Tumor necrosis factor enhances the neutrophil-dependent increase in endothelial permeability. J Cell Physiol 145:496-500.
14. Halstead SB. 1989. Antibody, macrophages, dengue virus infection, shock and hemorrhage: a pathogenic cascade. Rev Infect Dis II(Suppl):830-839.
15. Halstead SB, O'Rourke EJ, Allison AC. 1977. Dengue viruses and mononuclear phagocytes. II. Identity of blood and tissue leukocytes supporting in vitro infection. J Exp Med 146:218-229.
16. Ho L-J, Wang J-J, Shaio M-F, Kao C-L, Chang D-M, Han S-W, Lai J-H. 2001. Infection of human dendritic cells by dengue virus causes cell maturation and cytokine production. J Immunol 166:1499-1506.
17. Hober DL, Poli B, Roblin P, Gestas E, Chungue G, Granic P, Imbert JL, Pecarere R, Vergez-Pascal P, Wattre P, Maniez-Montreuil M. 1993. Serum levels of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6) and interleukin-1β (IL-1β) in dengue infected patients. Am J Trop Med Hyg 48:324-331.
18. Hober D, Shen L, Benyoucef S, DeGroote D, Deubel V, Wattre P. 1996. Enhanced TNF-α production by monocyte-like cells exposed to dengue virus antigens. Immunol Lett 53:115-120.
19. Huang YH, Lei HY, Liu HS, Lin YS, Liu CC, Yeh TM. 2000. Dengue virus infects human endothelial cells and induces IL-6 and IL-8 production. Am J Trop Med Hyg 63:71-75.
20. Jacobs M, Levin M. 2002. An improved endothelial barrier model to investigate dengue haemorrhagic fever. J Virol Methods 014:173-185.
21. Khanna M, Chaturvedi UC, Sharma MC, Pandey VC, Mathur A. 1990. Increased capillary permeability mediated by a dengue virus-induced lymphokine. Immunology 69:449-453.
22. Kiessling F, Kartenbeck J, Haller C. 1999. Cell-cell contacts in the human cell line endothelial cellV304 exhibit both endothelial and epithelial characteristics. Cell Tissue Res 297:131-140.
23. Kilks S. 1990. Antibody enhanced infection of monocytes as the pathogenic mechanisms for severe dengue illness. AIDS Res Hum Retroviruses 6:993-998.
24. Killen H, O'Sullivan MA. 1993. Detection of dengue virus by in situ hybridization. J Virol Methods 41:135-146.
25. Kurane I, Ennis FA. 1997. Immunopathogenesis of dengue virus infections. In: Gubler DJ, Kuno G, editors. Dengue and Dengue Hemorrhagic Fever. Colorado: CABI Publishing. p 273-290.
26. Kurane I, Kontny U, Janus J, Ennis FA. 1990. Dengue-2 virus infection of human mononuclear cell lines and establishment of persistent infections. Arch Virol 110:91-101.
27. Kurane I, Innis BL, Nimmannitya S, Nisalak A, Meager A, Janus J, Ennis FA. 1991. Activation of T-lymphocytes in dengue virus infection. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2 and interferon gamma in sera of children with dengue. J Clin Invest 88:1473-1480.
28. Langeler EG, van Hinsbergh VWM. 1988. Characterization of an in vitro model to study the permeability of human arterial endothelial cell monolayers. Thromb Haemost 66:240-246.
29. Le Naour R, Lussiez C, Raoul H, Mabondzo A, Dormont D. 1997. Expression of cell adhesion molecules at the surface of in vitro human immunodeficiency virus type-1 infected human monocytes: relationships with tumor necrosis factor α, interleukin 1β, and interleukin 6 syntheses. AIDS Res Hum Retroviruses 13:841-855.
30. Libraty DH, Pichyangkul S, Ajariyakhajorn C, Endy TP, Ennis FA. 2001. Human dendritic cells are activated by dengue virus infection: enhancement by gamma interferon and implications for disease pathogenesis. J Virol 75:3501-3508.
31. Lidbury BA, Mahalingam S. 2000. Specific ablation of antiviral gene expression in macrophages by antibody-dependent enhancement of Ross River Virus infection. J Virol 74:8376-8381.
32. Marianneau P, Steffan A-M, Royer C, Drouet M-T, Jaeck D, Kirn A, Deubel V. 1999. Infection of primary cultures of human Kupffer cells by dengue virus: no viral progeny synthesis, but cytokine production is evident. J Virol 73:5201-5206.
33. Murgue B, Cassar O, Deparis X. 2001. Plasma concentrations of sVCAM-1 and severity of dengue infections. J Med Virol 65:97-104.
34. O'Sullivan MA, Killen HM. 1994. The differentiation state of monocytic cells affects their susceptibility to infection and the effects of infection by dengue virus. J Gen Virol 75:2387-2392.
35. Pryor MJ, Carr JM, Hocking H, Davidson AD, Li P, Wright PJ. 2001. Replication of dengue virus type 2 in human monocyte-derived macrophages; comparisons of isolates and recombinant viruses with substitutions at amino acid 390 in the envelope glycoprotein. Am J Trop Med Hyg 65:427-434.
36. Rabiet M-J, Plantier J-L, Rival Y, Genoux Y, Lampugnani M-G, Dejana E. 1996. Thrombin-induced increase in endothelial permeability is associated with changes in cell-to-cell junctional organization. Arterioscler Thromb Vasc Biol 16:488-496.
37. Raghupathy R, Chaturvedi U, Al-Sayer H, Elbishbishi EA, Agarwal R, Nagar R, Kapoor S, Misra A, Mathur HA, Nusrat H, Azizieh F, Khan MA, Mustafa AS. 1998. Elevated levels of IL-8 in dengue hemorrhagic fever. J Med Virol 56:280-285.
38. Rigau-Perez JG, Clark GG, Gubler DJ, Reiter P, Sanders EJ, Vorndam AV. 1998. Dengue and dengue haemorrhagic fever. Lancet 352:971-977.
39. Rothman AL. 1997. Viral pathogenesis of dengue infections. In: Gubler DJ, Kuno G, editors. Dengue and dengue hemorrhagic fever. Colorado: CABI Publishing. p 245-259.
40. Rothman AL, Ennis FA. 1999. Immunopathogenesis of dengue haemorrhagic fever. Virology 257:1-6.
41. Royall JA, Berkow RL, Beckman JS, Cunningham MK, Matalon S, Freeman BA. 1989. Tumor necrosis factor and interleukin la increase vascular endothelial permeability. Am J Physiol 257:399-410.
42. Sahaphong S, Riengrojpitak S, Bhamarapravati N, Chirachariyavej R. 1980. Electron microscopic study of the vascular endothelial cell in dengue hemorrhagic fever. Southeast Asian J Trop Med Pub Health 11:194-204.
43. Shaio MF, Cheng SN, Yuh YS, Yang KD. 1995. Cytotoxic factors released by dengue virus-infected human blood monocytes. J Med Virol 46:216-223.
44. Wu S-J, Grouard-Vogel G, Sun W, Mascola JR, Brachtel E, Putvatana R, Louder MK, Filgueira L, Marovich MA, Wong H, Blauvelt A, Murphy GS, Robb ML, Innes BL, Birx DL, Hayes CG, Schlesinger Frankel S. 2000. Human skin Langerhans cells are targets of dengue virus infection. Nature Med 6:816-820.